|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM371378966 |
| 003 |
DE-627 |
| 005 |
20250306030258.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
240424s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2024.110224
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1237.xml
|
| 035 |
|
|
|a (DE-627)NLM371378966
|
| 035 |
|
|
|a (NLM)38648959
|
| 035 |
|
|
|a (PII)S1521-6616(24)00115-3
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Hisada, Ryo
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Potential therapies targeting metabolic pathways in systemic lupus erythematosus
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 17.05.2024
|
| 500 |
|
|
|a Date Revised 17.05.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2024 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a The pathophysiology of systemic lupus erythematosus (SLE) is multifactorial and involves alterations in metabolic pathways, including glycolysis, lipid metabolism, amino acid metabolism, and mitochondrial dysfunction. Increased glycolysis in SLE T cells, which is associated with elevated glucose transporter 1 expression, suggests targeting glucose transporters and hexokinase as potential treatments. Abnormalities in lipid metabolism, particularly in lipid rafts and enzymes, present new therapeutic targets. This review discusses how changes in glutaminolysis and tryptophan metabolism affect T-cell function, suggesting new therapeutic interventions, as well as mitochondrial dysfunction in SLE, which increases reactive oxygen species. The review also emphasizes that modulating metabolic pathways in immune cells is a promising approach for SLE treatment, and can facilitate personalized therapies based on individual metabolic profiles of patients with SLE. The review provides novel insights into strategies for managing SLE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a Immune cells
|
| 650 |
|
4 |
|a Metabolome
|
| 650 |
|
4 |
|a Systemic lupus erythematosus
|
| 700 |
1 |
|
|a Kono, Michihito
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 263(2024) vom: 01. Juni, Seite 110224
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnas
|
| 773 |
1 |
8 |
|g volume:263
|g year:2024
|g day:01
|g month:06
|g pages:110224
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2024.110224
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 263
|j 2024
|b 01
|c 06
|h 110224
|